Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pan Tumor”

143 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 143 results

Testing effectiveness (Phase 2)Looking for participantsNCT06003621
What this trial is testing

Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients

Who this might be right for
Solid Tumor, Adult
Omico 96
Testing effectiveness (Phase 2)Ended earlyNCT01806649
What this trial is testing

BKM120 in Esophageal Squamous Cell Carcinoma After Failure of First Line Chemotherapy

Who this might be right for
Esophageal Cancer
Prince of Songkla University 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320
What this trial is testing

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more
Immuneering Corporation 209
Testing effectiveness (Phase 2)UnknownNCT02268747
What this trial is testing

Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer

Who this might be right for
Skin Squamous Cell Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 43
Testing effectiveness (Phase 2)WithdrawnNCT02575508
What this trial is testing

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Who this might be right for
Colon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more
Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT02457351
What this trial is testing

Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study

Who this might be right for
Medical Oncology
Bayer 14
Testing effectiveness (Phase 2)Looking for participantsNCT05774899
What this trial is testing

CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC

Who this might be right for
Adenoid Cystic CarcinomaMetastatic Adenoid Cystic CarcinomaRecurrent Adenoid Cystic Carcinoma
Glenn J. Hanna 32
Early research (Phase 1)Ended earlyNCT02795819
What this trial is testing

Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer

Who this might be right for
Renal Cell CarcinomaSoft Tissue SarcomaMetastatic Disease
Virginia Commonwealth University 6
Not applicableLooking for participantsNCT06614179
What this trial is testing

A Pan-cancer Screening and Diagnosis Model Based on Abdominal CT Was Established

Who this might be right for
Abdominal Neoplasm
Xiangdong Cheng 100,000
Testing effectiveness (Phase 2)Study completedNCT01520870
What this trial is testing

Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.

Who this might be right for
GlioblastomaBrain Tumor, Recurrent
Grupo Español de Investigación en Neurooncología 49
Not applicableStudy completedNCT04532645
What this trial is testing

Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK

Who this might be right for
Ovary Cancer
AstraZeneca 342
Not applicableStudy completedNCT03172572
What this trial is testing

A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers

Who this might be right for
Pancreatic NeoplasmsPancreas CystPancreas Cancer
S (Sjors) Klompmaker, MD 4,220
Testing effectiveness (Phase 2)Study completedNCT03668119
What this trial is testing

Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

Who this might be right for
Pan Tumor
Bristol-Myers Squibb 212
Large-scale testing (Phase 3)UnknownNCT05698082
What this trial is testing

FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues

Who this might be right for
Colorectal CancerMonkey Pox
xiaoliang Huang 120
Early research (Phase 1)Study completedNCT01570296
What this trial is testing

A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR

Who this might be right for
Non-Small Cell Lung CancerSolid Tumors
National Cancer Centre, Singapore 38
Testing effectiveness (Phase 2)Looking for participantsNCT04645160
What this trial is testing

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

Who this might be right for
CholangiocarcinomaBile Duct NeoplasmBiliary Tract Malignancy
National Cancer Institute (NCI) 31
Early research (Phase 1)UnknownNCT03991559
What this trial is testing

A Safety Study of the Pan-immunotherapy in Patients With Unresectable/Metastatic Solid Tumors or Lymphomas

Who this might be right for
Solid TumorLymphoma
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06993844
What this trial is testing

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Breast Cancer
Ensem Therapeutics 233
Not applicableLooking for participantsNCT06451445
What this trial is testing

A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 100
Early research (Phase 1)Active Not RecruitingNCT04913285
What this trial is testing

Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Who this might be right for
Solid Tumor, AdultNon-small Cell Lung CancerMelanoma
Pierre Fabre Medicament 400
Load More Results